CND Life Sciences

Scottsdale, AZ · Founded 2017 · Privately Held (backing)

Developer of a medical diagnostic platform designed to detect key pathological markers in the peripheral nervous system. CND Life Sciences is based in Scottsdale, AZ and was founded in 2017. Its last reported valuation was $30.5 million in Mar 2023. It has raised $29.3 million across 7 recorded rounds; the latest was a $4.3 million debt round in Jun 2026.

Last reported valuation
$30.5M
Oct 2026
Priced at
—
Total raised
$29.3M
Last round
Debt
Jun 2026
What is CND Life Sciences worth?
$30.5Mlast reported valuation · Oct 2026

CND Life Sciences's last reported valuation, Mar 2023. Nothing priced has surfaced since.

Free account
More of CND Life Sciences with a free account
  • ·The complete investor list: 14 names
  • ·Watch CND Life Sciences: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Valuation timeline

0 priced rounds · 32 daily marks since · Sep 2026 – Oct 2026
▮▮
Markrounds hold their value until the next priced eventMark, today
log scale
Post-money values unlock with a free account.Unlock the axis

Membership and data by Private Market View

CND Life Sciences funding history

7 rounds
DateRoundRaisedPost-money
Jun 2026Debt$4.3M▮
Feb 2025Early Stage VC$8.6M▮
Mar 2024Seed Round$2.0M▮
Jul 2023Debt$1.5M▮
Sep 2022Seed Round$4.5M▮
Oct 2021Seed Round$4.2M▮
+ 1 earlier rounds · a free account shows the full history
Unlock post-money valuations

Membership and data by Private Market View

CND Life Sciences valuation

CND Life Sciences's last reported valuation was $30.5 million in Mar 2023. No priced round, secondary trade or fund mark has surfaced since.

How much has CND Life Sciences raised?

CND Life Sciences has raised $29.3 million across 7 recorded rounds since 2021. The largest was an $8.6 million early-stage round in Feb 2025; the most recent was a $4.3 million debt round in Jun 2026.

CND Life Sciences has filed 10 Form Ds with the SEC since 2021, most recently in May 2025 ($8.6 million sold to 38 investors).

How CND Life Sciences's valuation is determined

Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.

For CND Life Sciences, the most current credible signal sets the number and the older ones confirm it: a live secondary-market price first, then three or more recent prints, then institutional fund marks, and otherwise the last priced round, which never decays. The valuation is the last round’s post-money moved by the price change since that round, so no share count is assumed. Today it is set by last reported valuation. Question about this number? Full methodology →

Frequently asked about CND Life Sciences

What is CND Life Sciences worth?
CND Life Sciences is valued at $30.5M as of Oct 2026. CND Life Sciences's last reported valuation, Mar 2023. Nothing priced has surfaced since.
How much has CND Life Sciences raised?
CND Life Sciences has raised $29.3M in total funding across 7 recorded rounds.
When did CND Life Sciences last raise?
CND Life Sciences last raised in Jun 2026 (Debt), raising $4.3M.